A Look at America’s First CRISPR Clinical Trial

It was only a matter of time before CRISPR/Cas9, the gene editing phenomenon that took the scientific world by storm, left the lab and entered the patient. At last, initial findings from America’s first clinical trial using CRISPR-edited immune cells suggest the approach is safe and feasible.